Why AI matters at this scale

Arizona State University's Center for Health Promotion and Disease Prevention (CHPDP) is a large-scale academic research center dedicated to improving public health through community-engaged research, intervention development, and disease prevention programs. Operating within a major R1 public university, it leverages interdisciplinary expertise to address chronic diseases, health disparities, and wellness across populations. Its work generates vast amounts of quantitative and qualitative data from clinical trials, community surveys, and environmental studies.

For an organization of this size (5,001-10,000 employees within the broader university context) and mission, AI is not a luxury but a force multiplier. The center's effectiveness hinges on translating complex, multi-source data into actionable prevention strategies. Manual analysis is too slow and limited for the scale of modern public health challenges. AI enables the center to move from descriptive reporting to predictive analytics, identifying at-risk communities before crises emerge and personalizing interventions to improve outcomes. At this institutional scale, there is both the data volume and the operational need to justify investment in AI capabilities, positioning CHPDP to lead in the next generation of evidence-based public health.

Concrete AI Opportunities with ROI Framing

1. Predictive Risk Modeling for Targeted Outreach: By applying machine learning to integrated datasets (EHR, zip code-level social determinants, pollution data), CHPDP can build models predicting diabetes or hypertension hotspots. The ROI is clear: shifting resources from broad awareness campaigns to targeted interventions increases program efficacy, improves community health metrics, and strengthens grant proposals with predictive evidence, directly attracting more research funding.

2. NLP for Accelerating Research Synthesis: AI-powered natural language processing can analyze decades of public health literature and internal project reports in weeks, not years. This dramatically reduces the time researchers spend on literature reviews for new studies, accelerating the hypothesis generation and grant writing cycle. The ROI is measured in faster time-to-science, more publications, and a higher volume of competitive grant submissions.

3. AI-Enhanced Participant Engagement and Retention: Implementing an AI-driven platform that analyzes participant interaction data (app usage, survey responses) can identify individuals likely to drop out of longitudinal studies or wellness programs. Automated, personalized nudges (messages, resource links) can then boost retention. The ROI is substantial: higher retention rates protect the statistical power and validity of long-term studies, safeguarding millions in research investment and ensuring reliable results.

Deployment Risks Specific to This Size Band

Deploying AI in a large university-affiliated center presents unique risks. Data Governance and Privacy is paramount; integrating sensitive health data across projects must navigate stringent IRB protocols, HIPAA, and FERPA, requiring robust data anonymization and access controls. Funding and Resource Allocation is a challenge; while the university has scale, AI projects may compete with traditional research for internal funding, and grant cycles are slow, potentially stalling pilot projects. Integration with Legacy Systems is complex; large institutions often have entrenched, disparate data systems (REDCap, EHRs, separate survey tools), making the creation of a unified AI-ready data layer a significant technical and bureaucratic hurdle. Finally, Cultural Adoption among research faculty and community health staff—who may be skeptical of "black-box" models—requires careful change management and demonstrable, transparent benefits to gain trust.